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Abstract 
Background:   Gestational diabetes mellitus is increasing enormously worldwide in the 
recent decades especially in developing countries. The prevalence of Gestational Diabetes 
mellitus (GDM) differs depending on the regions and the country. Nearly half of women with 
a history of GDM develop type 2 diabetes within five to ten years after delivery.  Out of 25 
pregnancies 1 develop GDM which is associated with complications in the period 
immediately before and after birth.  It is one of the causes of maternal and fetal mortality and 
morbidity. Due to lack of data on prevalence of GDM, particularly from Nepal we conducted 
the study.   
Objectives: The goal of the study is to determine the prevalence and to identify associated 
risk indicators of GDM. 
Methods:  
Design & source of data: A cross sectional epidemiological study was conducted in urban 
antenatal clinic in Nepal for 6 months (1
st
 July-31
st
 December 2013). 510 eligible pregnant 
women who were willing to take part in the study between 24 and 28 weeks of pregnancy 
were the recruited participants. All of them underwent 50gm GCT followed by 75gm OGTT, 
if the value of GCT≥ 140mg/dl, to confirm GDM. Descriptive, univariate and multivariate 
binary logistic regression was done to see the effect modification of GDM on different 
variables.  
Results: GDM was diagnosed in 22 (4.3%) women.  In this study, the progressing maternal 
age was independent risk indicators for GDM in univariate and multivariate analysis. In 
overweight and obesity BMI was found significant in univariate analysis. The non-
vegetarians had 70% risk of being overweight and obese and 3 folds probability to develop 
GDM than vegetarians. No significant association with GDM was found for physical activity, 
parity, education, occupation, socio-economic status. 
Conclusion: Appropriate intervention is needed for control and risk indicator modification 
for GDM. Absence of association of GDM with important risk indicators is due to lack of 
statistical power. 
Keywords: gestational diabetes mellitus, prevalence, risk indicators, Nepal, developing 
country. 
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1.1 Country profile 
Nepal is a beautiful country with natural beauty; however, it is among the poorest and least 
developed countries in the world. It has been seen that about one-quarter of its population 
living below the poverty line. It is estimated that 25.2% of population are below the poverty 
line.   
1.1.1 Geography 
Map of Nepal 
 
Map of Nepal with its surrounding boundary (World Fact Book[WFB], 2014) 
Location: 
 Nepal is a landlocked country, sandwiched between China on the north and India on the east, west 
and south. It is situated between the latitudes of 28 00 N, 84 00 E. It has the eight of world's 10 
highest peaks, including Mount Everest and Kanchenjunga the world's tallest and third tallest 
mountains respectively. The temperature varies from cool summers and severe winters in north to 
subtropical summers and mild winters in south. 
Local currency: A Nepalese rupee (NPR) is the local currency and the exchange rate per US dollar 
is approximately 100 NPR.  
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1.1.2 Economy  
Nepal greatly depends on remittances, which amount to as much as 22-25% of GDP.  Per capita 
(PPP) is $1,500 for nepalese people. Agriculture is the main source of the income providing a 
livelihood for more than 70% of the population and accounting for a little over one-third of GDP. In 
2011 heath expenditure is 5.4% GDP and people have to spend money by themselves for basic health 
care requirements.  
1.1.3 People and culture  
Total population of Nepal is 26,494504 (CBS, 2012). The population is growing at the rate of 1.82% 
. The birth rate estimation for 2014 is 21.07 births/1,000 populations. 
Majority of Nepalese are Hindus who are about 81.3%, Buddhist is 9%, and rest are of other religion. 
Nepali is an official language and 123 other languages are also spoken for communication. 
1.1.4 Education  
Total literacy rate is 57.4% and female literacy rate is 46.7% and male is 71.1%. In 2010 education 
expenditure was 4.7% of GDP. 
1.1.5 Life style and physical activity:  
Nepal is a male dominating society, women take care of the household activity like cooking, 
cleaning, washing; Most of the Nepalese women do not perform extra physical activity apart from 
their daily domiciliary activity.  
1.1.6 Food habit:   
Rice is a staple food of Nepal and is taken rice at least twice a day with lentils and vegetables. Meat 
products are taken twice or thrice a week. Fruits and salads are taken frequently but not on daily 
basis.  
1.1.7 Trend of urbanisation:  
People are moving towards the urban area for job opportunity, good living standard and health care 
facility. Nearly 17% of total population in the year 2011 live in urban area. In 2009 there were 
990,000 people were residing in Kathmandu (capital) alone. 
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1.1.8 Overall health status in Nepal:  
Maternal mortality rate is 170 deaths/100,000 live births (2010). Infant mortality rate is 40.43 
deaths/1,000 live births. Death rate is 6.62 deaths/1,000 populations (2014 est.) HIV deaths are 4100 
in 2012 est. Nearly 50, 0000 .The major infectious diseases are food or waterborne diseases: bacterial 
diarrhoea, hepatitis A and E, and typhoid fever. Other vector borne disease: Japanese encephalitis, 
malaria, and dengue fever (2013). The adult prevalence rate of obesity 1.4% (2008). Hospital bed 
density is 4.7 beds/1000 populations in 2009 census. Around 29.1% of Children under the age of 5 
years were underweight (2011). (World fact book,2014) 
1.2 Diabetes mellitus –Background  
Diabetes mellitus is chronic hyperglycaemia with disorders of carbohydrate, fat and protein 
metabolism and resulting from defects in insulin secretion, insulin action, or both. Diabetes mellitus 
leads to progressive development complications of retinopathy with potential blindness, nephropathy 
that may lead to renal failure, and/or neuropathy with risk of foot ulcers. People with diabetes are at 
increased risk of cardiovascular, peripheral vascular and cerebrovascular disease (WHO, 1999). 
Types of diabetes mellitus 
1. Type 1 formerly known as IDDM or juvenile or childhood onset fail to produce insulin which 
is essential for lowering the blood sugar. It is mainly seen in children and adolescents. Daily 
administration of insulin is required for survival. The cause is unknown and unpreventable 
with the current knowledge. 
2. Type 2 formerly known as NIDDM or adult onset where the body is unable to respond 
properly to the produce insulin by pancreas. It is more common as 90% of people are 
suffering from Type 2 diabetes around the world .This type of diabetes is mainly due to 
obesity and physical inactivity. Type 2 DM was seen in adult only, but now it occurs in 
children and adolescent as well. People with type 2 may require oral hypoglycaemic drugs or 
need insulin injections (WHO, 1999). 
3. Gestational Diabetes Mellitus 
4. Other specific type of diabetes e.g. Genetic defect of β cell function; Genetic defect in insulin 
processing or insulin action; Disease of the exocrine pancreas; Endocrinopathies; Drug or 
chemical induced diabetes; Infection; Uncommon forms of immune mediated diabetes; 
Genetic syndrome. 
  Page 
12 
 
  
1.2.1 The global burden of diabetes and GDM 
The global prevalence of diabetes is 16.9% and 80%of them live in low and middle-income 
countries. It is estimated that 382 million people have diabetes and the number will rise to 592 
million by 2035 in less than 25 years. It is miserable that around 175 million people with diabetes 
are not diagnosed. Every six seconds a person dies from diabetes. In 2013, 5.1 million died due to 
diabetes. IDF estimates that number of live births with hyperglycaemia in pregnancy is 21.4 million 
which accounts for 16.8% of total live births in 2013. South-East Asia Region has the highest 
prevalence of 25.0% compared with 10.4% in the North America and Caribbean Region. It develops 
in 1 in 25 pregnancies worldwide and is associated with complications in the period immediately 
before and after birth. Nearly half of women with a history of GDM develop type 2 diabetes within 
five to ten years after delivery (IDF, 2013). 
1.2.2 Diabetes in Nepal 
The reports published from Nepal on prevalence of diabetes are less in numbers. The true magnitude 
of diabetes has remained unknown as there is no nationwide prevalence surveys of diabetes have 
undertaken in Nepal. In a central hospital in Nepal, out of total medical admissions, the proportion of 
diabetic patients increased over 4 years from 2.6% in April 1990-March 1991 to 5.6% in April 1993-
March 1994 (Singh, Bhattarai &Maskey, 1995). The extent of the problem may be even greater since 
fasting glucose alone detects only half of diabetes defined by 2-h glucose in Asian populations. The 
Nepal Diabetes Association reported that diabetes affects approximately 15% of people ≥ 20 years 
and 19% of people ≥ 40 years of age in urban areas (Bhattarai & Singh, 2007). According to WHO, 
diabetes affects more than 436,000 people in Nepal, and this number will rise to 1,328,000 by 2030 
(Wild, Roglic et al., 2010). The percentage of diabetic patients has increased from 19.04% in 2002 to 
25.9% in 2009 in Nepal (Dulal & Karki , 2009). Nepal has not been different from other countries 
and the diabetes are growing gradually, it is mainly because people have become health conscious, 
they prefer to do lab investigation and diabetes is detected early. Today laboratory technology is 
advanced for identifying the diseases so numbers of cases are rising for many illnesses. Similar has 
happened in the case of diabetes as well. In Nepal such technology has been introduced so diseases 
become noticeable. 
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1.3 Gestational Diabetes Mellitus 
Gestational Diabetes is defined as onset of glucose intolerance at varying degree or first diagnosed 
during pregnancy (Metzer & Coustan, 1998). GDM has a potential risk to the mother as well as the 
fetus. Out of the 8 goals stated by the United Nation Millennium Development Goal (MDG), 4
th
 goal 
targets the reduction in child mortality and 5
th
 goal states the upgrading the maternal health. GDM, 
accounts for the health of mother and child. GDM is responsible for progression of the type 2 
diabetes in about 50% of GDM mothers (IDF, 2013).  
Especially in south Asian countries, there is a growing prevalence of GDM. In India GDM has been 
found to be more common in women living in urban areas than in women living in rural areas 
(Zargar, et al., 2004). The prevalence of GDM is high in India and fluctuates according to 
geographical areas and diagnostic methods used (Zargar, Sheikh & et.al, 2004, Divakar, Tyagi et.al 
2008). The prevalence of GDM in India ranges from 3.8% to 21% depending upon the diagnostic 
method used (Jali et al., 2011).According to a random national survey conducted in 2004 the GDM 
prevalence was 16.55% (seshiah, Balaji et. al., 2004)). In 2008, a hospital based survey showed a 
combined prevalence of GDM and IGT to be 21.6% (Swami, Mehetre et.al, 2008). 
 A study conducted during 2005-2007 at Patan hospital in Nepal found the incidence of GDM 0.4% 
(Sharma & Shrestha, 2010). Another study at Dhulikhel hospital detects 0.75% of GDM by using 
Carpenter Coustan criteria (Shrestha & Chawla, 2011).. Effective preventive strategy/s reduces GDM 
to some extent helping to strengthen the MDG. Due to lack of proper data, particularly in Nepal, the 
prevalence of GDM and risk indicators are not known. Hence our study mainly focuses on the 
prevalence and the risk factors of GDM in Nepal. 
1.3.1  Prevalence of GDM 
Recent data show that gestational diabetes mellitus (GDM) prevalence has increased by 10–100% in 
several race/ethnicity groups during the past 20 years. In the U.S., Native Americans, Asians, 
Hispanics, and African- American women are at higher risk for GDM than non-Hispanic white 
women (Doery,Edis, & et al., 1989; Green, Pawson, et al., 1990; Solomon,Willet et al, 1997; 
Thorpe,Berger et al,2005). The proportion of pregnancies complicated by GDM in Asian countries 
has been reported to be lower than the proportion observed in Asian women living in other continents 
(Yang, Hsu, et al., 2002).  A study performed in Australia found that GDM prevalence was higher in 
women whose country of birth was China or India than in women whose country of birth was in 
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Europe or Northern Africa (Beisher, et al., 1991). GDM prevalence was also higher in Aboriginal 
women than in non- Aboriginal women (Ishak, & Petocz, 2003). In Europe, GDM has been found to 
be more common among Asian women than among European women (Dornhost, Paterson, et al., 
1992).  
A hospital based cross sectional study is conducted to observe the prevalence of GDM in Nepal. 
There are very few studies regarding GDM in Nepal so there is a need to do research on GDM to 
know more about it for the betterment of the health of mother and child. It is a public health issue and 
it should be monitored carefully in order to save the life of mother and child. In poor resource setting 
country like Nepal disease remains hidden and noticed only after the complication arises. 
1.3.2 Glucose intolerance in normal and GDM pregnancy 
 Pregnancy is a normal phenomenon, there are many hormones act during pregnancy. Insulin 
resistance begins in mid of second trimester and continues to third trimester as well. Insulin 
resistance is due to placental hormones; though β cells of pancreas increases the production of 
insulin to cope with the insulin resistance during pregnancy, the changes in the circulating glucose 
level during pregnancy is low in divergence to extreme changes in insulin sensitivity (Buchanan & 
Xiang, 2005).  Insulin resistance increased in GDM pregnancy than normal pregnancy. The 
metabolism of Carbohydrate, protein and fat are affected by insulin resistance. Once the baby was 
born, GDM may disappear but to some it may persist as diabetes, impaired fasting glucose even 
after delivery.  There is chance of recurrence in the following pregnancy or any time after delivery 
(Ben, Yogev &Hod 2004). 
1.3.3  Pathogenic factor for gestational diabetes  
Pregnancy, though a normal condition insulin resistance occurs with a compensatory increase in β-
cell response resulting in hyperinsulinemia. Insulin resistance usually happens in the second trimester 
and progresses throughout the third trimester of the pregnancy. 80% insulin sensitivity is reduced by 
placental hormones, such as progesterone, cortisol, placental lactogen, prolactin, and growth 
hormone. The insulin resistance causes adequate supply of glucose by changing the maternal energy 
metabolism from carbohydrates to lipids (Cianni, Miccoli, et al., 2003). 
“The other suggests that Genetic GDM where the autoimmune and insulin resistant forms of diabetes 
outside of pregnancy, diseases for which GDM is often a precursor, are heritable, and some 
contributory genetic variants have been defined. Evidence was presented that some of the variants 
may contribute to GDM or its physiological phenotypes (insulin resistance, cell dysfunction), but the 
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studies to date are relatively small, as are the potential genetic contributions. The contribution of 
genetics to other forms of GDM is not well established. Placental GDM : Evidence presented that 
was obtained from human term placentas studied in vitro indicates that placental glucose transport 
and metabolism are normal in GDM pregnancies, despite increased glucose fluxes from mother to 
fetus that result from increased glucose concentrations on the maternal side” (Metzer, Buchanan & 
coustan , 2007). 
1.3.4  Screening of GDM 
 Screening criteria in hospital varies and have their own protocol with different diagnostic norms 
used in Nepal. However in two recent comprehensive reviews, evaluated the screening and diagnosis 
protocol for GDM, all pregnant women should be assessed for clinical characteristics to determine 
the risk of GDM by a 50-g oral glucose-challenge test (GCT), usually between 24 and 28 weeks of 
gestation, followed by an oral glucose tolerance test (OGTT) if the serum glucose concentration at 
screening is high unless they have a low-risk clinical profile (Hanna and Peters, 2002, Kjos and 
Buchanan, 1999).  We will highly suggest doing GCT screening irrespective of risk indicators prone 
to GDM or not, as it is very crucial. 
 Women using a glucose cut-off value of ≥ 140 mg/ dl (7.8 mmol/ l) the GCT is positive in 14–18%, 
and using a cut-off level of ≥ 130 mg/dl (7.2 mmol/ l) the positivity is in 20–25%, with sensitivity 
rates of approximately 80% and 90% for the diagnosis of GDM respectively. The lower cut-off value 
also lowers the specificity by 25% (Hanna and Peters, 2002). The hospital where we conducted the 
study performed the 50 gm GCT to pregnant women visiting between 24 and 28 weeks. The cut off 
level taken is ≥140mg/dl followed by OGTT to confirm GDM 
1.3.5 Diagnostic criteria proposed  used in different studies on GDM 
The diagnostic criteria for GDM performed by country, committee, and people vary. The ADA 
expert committee (1997) recommended a screening test performed with a 50 gm glucose test 
between 24 and 28 weeks of pregnancy. Those values were based on the cut off value proposed by 
O‟Sullivan and Mahan‟s value. NDDG (National Diabetes Data Group) converted these to plasma 
values in 1979. There was a disagreement on O‟Sullivan and Mahan‟s value interpretation. The 
substrate measured were changed to venous plasma from venous blood, the laboratory technique 
was transferred to enzymatic method from Somogyi-Nelson method. In 1982 Carpenter and Coustan 
modified on the NDDG based O‟Sullivan and Mahan‟s value. The value proposed by Carpenter and 
Coustan was recommended by the Fourth International Workshop-Conference on Gestational 
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Diabetes Mellitus (Metzer& Coustan, 1998). Some follow WHO criteria, ADA criteria, IADPSG 
criteria, Carpenter Coustan criteria and many more. 
The diagnosis of gestational diabetes mellitus at any time during pregnancy should be based on any 
one of the following values:  
 Fasting plasma glucose = 5.1-6.9 mmol/l (92 -125 mg/dl)  
 1-h post 75g oral glucose load >=10.0 mmol/l (180 mg/dl)*  
 2-h post 75g oral glucose load 8.5 – 11.0 mmol/l (153-199 mg/dl) 
*There are no established criteria for the diagnosis of diabetes based on the 1-hour post-load value. 
The quality of evidence is very low and strength of recommendation is weak. 
The recommended glucose cut-off value for GDM corresponds to those proposed by IADPSG and is 
lower than those recommended by earlier guidelines. Unlike earlier guidelines, they are based on the 
association of plasma glucose and adverse maternal and neonatal outcomes during pregnancy, at birth 
and immediately following it. The difference from IADPSG guidelines is that these new WHO 
guidelines set a range of plasma glucose levels to distinguish diabetes in pregnancy and GDM 
(WHO, 2013). 
1.3.6 Clinical importance of GDM 
Clinically GDM is a high risk factor for mother and child. If left undetected or untreated d it may 
lead to serious complication to both the mother and the child. The immediate complication to the 
mother is pre- eclammpsia, obstructed labour, caesarean delivery and in delayed complication due to 
rise in blood sugar lead to infection, delayed wound healing. The child may be hypoglycaemic, 
macrosomic, shoulder dystocia or may lead to intrauterine death. Hence it becomes compulsory for 
all the pregnant women to undergo random blood glucose at the first antenatal visit to detect 
diabetes in pregnancy.  
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1.3.7 Risk indicators for GDM  
 Repeatedly stated risk indicators for GDM are as follows, increase maternal age, parity, increasing 
weight, positive family history of diabetes, previous history of GDM, less physical activity, previous 
history of macrosomic delivery of the baby. A population based study conducted in Sweden found 
increasing maternal age, and high BMI were risk factor for increase OGTT values (Ben - Haroush, 
Yogev & Hod, 2004).  
A study conducted in U.S.  Showed a risk of developing GDM is 2, 4, 8 times higher among 
overweight, obese and severely obese women compared with normal weight pregnant women (Chu, 
Callaghan, et.al, 2007).  
Universal screening on GDM of Italian women GDM was found to be higher with increasing age, 
prepregnancy overweight, positive history of diabetes short stature (Di, Volpe, et al., 2003). A 
population based cross sectional study conducted in Australia found increasing maternal age and 
ethnic factors ( non- Caucasian ethnicity) result in increasing GDM rates (Carolan, Davey,et al., 
2012).  A study conducted in India had the prevalence proportion GDM increased with gravida 
(Seshiah, Balaji, et al., 2004). There was high prevalence of GDM in multigravida than in 
primigravida. 
1.3.8  Complication of GDM 
GDM has adverse effect on both mother and fetus. They are listed as fetal and maternal problem. 
Fetal complications include macrosomia, neonatal hypoglycaemia, perinatal mortality, congenital 
malformation, hyperbilirubinemia, polycythaemia, hypocalcaemia, and respiratory distress syndrome. 
This results from maternal hyperglycaemia causing fetal hyperinsulinemia. Delayed impediments to 
the young generation of people include an increased risk of glucose intolerance, and obesity. (ADA,  
2004;  Metzger & Coustan , 1998; Casey , Lucas,et al., 1997; Kjos & Buchanan , 1999) 
Maternal factors associated with an increased incidence of macrosomia include hyperglycaemia, 
(Metzger & Coustan, 1998; Casey,et al., 1997; Kjos & Buchanan , 1999) high BMI,  (Ciann, Miccoli 
et al ., 2003; Di,et al 2003; Casey et al., 1997; Kjos & Buchanan , 1999) ,older age, preeclampsia and 
multiparity (Ciann, Miccoli et al, 2003; Casey et al .,1997),  shoulder dystocia, and an increased rate 
of caesarean deliveries. More important is women with GDM have an increased risk of developing 
diabetes after pregnancy when compared to the general population, with a conversion rate of up to 
3% per year (Casey et al 1997). 
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Though some studies show no maternal and fetal complications. In Saudi Arabia Nasrat et al 
observed 212 women with untreated IGT and same number of women with normal glucose 
tolerance and concluded that IGT had no adverse pregnancy outcome (Nasrat, Augensen& 
Shalhoub, 1994). A study in Mauritius by Ramtoola et al., could not find excess perinatal mortality 
in 267 pregnant women with IGT compared with a background population (Ramtoooola, Home 
&Damry, 2001). 
Whereas, Moses and Calvert (Australia) found the glucose level should be close to normal during 
pregnancy. They found the there was an association between blood glucose and the proportion of 
assisted deliveries and the proportion of infants admitted in ward with glucose tolerance (Moses 
&Calvert, 1995). Ramachandann et al conducted a study in south India GDM pregnancy had high 
macrosomia  and premature deliveries than those who had no GDM (Ramachandran, Snehalatha, 
Clementina, et al.,1998)  
A study conducted in Pakistan showed pre-eclampsia and caesarean delivery was highest with 
abnormal glucose tolerance test. However for abnormal GCT and normal GTT the incidence of 
macrosomic child had mounted up (Khan, Hashmi &Rizvi, 1995).  
1.3.9 Effects of GDM on maternal and child health 
The MDG has clearly stated that 4 and 5 reduce child mortality and improve maternal health 
respectively.  GDM is a warning to both the mother and child. Once detected the treatment has to be 
started in order to be on a safer side to prevent any serious complication to occur during pregnancy 
and child birth. The delivery should be safe for the mother and the child as well because GDM 
causes problem to both. 
1.3.10 Maternal and child health service in Nepal 
The cost-effective interventions exist across the continuum of maternal to child survival at each level 
of the health system that can contribute to achieve the Millennium Development Goals 4 and 5. 
However, implementation inefficiency, low coverage and equity gaps along this continuum remain a 
serious challenge to Nepal‟s efforts to achieve these goals (KC, Bhandari, 2011). Due to lack of 
resources maternal and child health situation is critical. It needs to be worked out from the 
government level to the grass root level to conduct a safe delivery saving both lives. 
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Component of antenatal care in public health clinic 
1. Proper history taking 
2. Height measurement  of the pregnant women 
3. Weight measurement of the pregnant women 
4. General examination of the pregnant women 
5. Physical examination  for anaemia, jaundice,  oedema 
6. Vitals has to be taken : BP, Pulse temperature, respiration 
7. Fundal height  
8. Fetal heart sound 
9. Tetanus toxoid vaccination 
10. Lab investigation: Hb%, RBG, urine routine and for acetone, blood grouping, etc. 
11. Proper information must be given about the pregnancy and also letting them know the 
danger sign such as fever, burning micturition, foul discharge from vagina eruption of the 
water bag, less fetal movement etc. 
12. USG (Ultrasonography) to see the fetal well-being and the gestation age. 
 
1.4 Relevance (statement of the problem) 
People suffering from diabetes, in urban area are more than that in rural area. A survey conducted in 
urban Nepal between 2001 and 2002 shown that 10.8% suffered from diabetes and 13.2% pre-
diabetes respectively in males, and that for females being 6.9% and 10.2%, respectively (Shrestha, 
Singh, Bhattarai, 2006).  
GDM has to be identified timely in order to avoid risk and complication to the mother and the child. 
In a developing country like Nepal due to proper lack of resources and clinical investigation the 
pregnant women have to bear serious consequences putting their life at a stake. Initiatives have to be 
taken for the pregnant women for proper investigation for the type of screening which would identify 
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the disease on time. Thus help to save the lives of two. Traditionally, after delivery women in Nepal 
are often prevented from engaging in any activities such as travelling, washing, minor work activities 
and consuming calorie-rich foods that are high in fat content. This custom, which is accompanied by 
traditional „oil massage‟ may last from a few weeks up to three months. The recent study found an 
average weight gain is six months after delivery is around 15.9 kg. After few months, it is difficult to 
loose gained weight. Increased body weight in women of childbearing age puts them at increased risk 
of developing gestational diabetes in subsequent pregnancies and diabetes later in life (Bhattarai & 
Singh, 2007). In order to control this situation one needs to identify the risk indicators for GDM 
Nepal Diabetic Association has faced difficulties convincing health planners that a vital goal is to 
prevent of type 2 diabetes.  The nutritional status of women must be checked; particularly those of 
childbearing age and correlate with GDM (Bhattarai & Singh, 2007). Reports claim that 40-66% of 
early pregnancy can detect GDM; however conflicting studies on glucose screening made it difficulty 
in detecting GDM on time (Meyer, Carbone et. al, 1996). 
1.5 Justification of the study 
Gestational Diabetes Mellitus causes life threatening complication to the mother and the child. 
Prevalent progression of GDM leads to type 2 diabetes in future. GDM is a preventable disease so in 
order to avoid complication it becomes necessary to identify the risk indicators at the earliest. This 
would help the mother to take a preventive step for herself and the child as well. The MDG 4 and 5 
also states reduce child mortality and improve maternal health. Pregnancy with complication has to 
be identified and timely action to be taken for safer deliveries by skilled personnel. Saving the two 
lives are truly a noble deed. It is the duty of the researcher to make the public realize the importance 
of GDM. Research will let people know the prevalence, risk factors, prevention of the disease. It is 
very necessary to motivate people regarding GDM. 
There are very few studies conducted in Nepal in regard to GDM so people are not aware of the 
disease. They lack total knowledge about this disease. The person who knows also does not know 
very well. There is no proper data about its aetiology, prevalence, risk factors, and prevention on this 
disease. Due to lack of information for the providers they also could not generate the exact 
information to the target population. Right information on GDM has to be given to all the pregnant 
mothers. As already told the studies done in Nepal were few it is the right of the Nepalese citizen to 
get to know the disease in the best possible way. 
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1.6 Research question, hypothesis and study objectives 
1.6.1 Hypothesis 
1. There is a high prevalence of gestational Diabetes Mellitus in Nepal. 
2. The risk indicators of GDM  are  advancing maternal age, overweight and obesity, reduce 
physical activity, positive family history, previous positive history of GDM , diet (non vegetarian 
diet) 
1.6.2 Research question 
1. What is the prevalence of GDM in urban antenatal clinic in Nepal? 
2. What are the risk indicators and association with GDM in Nepal? 
1.6.3 Objectives of the study 
Primary objective 
To determine the prevalence of gestational diabetes mellitus in urban antenatal clinic in Nepal.  
  Secondary objectives 
1. To examine the difference in prevalence of GDM in normal and overweight mother   
2. To explore the GDM in the context of socio demographic status such as age, economic status, 
family history, parity, education, physical activity, diet. 
. 
. 
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2 Material and method 
2.1 Target population 
 The target population was pregnant woman of reproductive age (15-49) years visiting antenatal 
clinic at KMC (Kathmandu Medical College).  
2.2 Study population 
The study population was pregnant women between 24 and 28 weeks gestation who are coming to 
the Kathmandu medical college and teaching hospital for their antenatal check-ups. 
 2.3 Study design 
A hospital based cross sectional study was designed for the collection of the data. The study 
design was purely quantitative and observational. The data was collected from only one hospital. 
The necessary information was collected from the participants through the prepared set of 
questionnaire. The question was asked individually to each participant. 
2.4 Study hospital 
The data was collected from participants visiting Kathmandu medical and teaching hospital for 
antenatal check-ups. 
2.5 Research tool/instrument 
The  research tool used for the data collection was  
i. Questionnaire ( Appendix 2) 
2.6 Source of data 
i. Answers given by the participants to the questionnaire 
ii. Antenatal record book 
iii. Lab investigation report 
iv. Height and weighing machine kept at KMC. 
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2.7 Inclusion criteria 
i. Reproductive age from (15-49) years, pregnant woman. 
ii. Pregnant women between 24 and 28 weeks of gestation 
iii. Pregnant women who are eligible and willing to take part in the study. 
2.8 Exclusion criteria 
i. Significant maternal diseases like connective tissue diseases, endocrine diseases,   asthma, 
chronic liver disease etc. 
ii. Frank diabetes (Diabetes prior to pregnancy). 
iii. Twin or multiple pregnancy. 
2.9 Sample size determination of primary study 
Calculation is done in the following way; 
n= Z² x PQ/d
2 
 n = required sample size 
Z = confidence level at 95% (standard value of 1.96) 
P = estimated prevalence of GDM is about 6.3%
 
  (Jiwani ,  Marseille , Nicolai et.al , 2012) 
Q=1-P i.e. 0.72 
d = margin of error i.e. (0.05)
 
Formula:  
n= = Z² x PQ/d
2=
 (1.96)
2
(.06) (1-0.06)/ (0.05) 
2
 
                       =3.84*.06*0.94/ 0.0025 
                       =86.67  
Estimated  response rate is 80 %i. e. 0.8 
                        86.67/0.8= 108 (required sample size). 
Sample size 
The sample size of the participants was 510 during the field work period. 
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2.10 Sampling procedure 
Data was collected from the research participants who were eligible for the study. 
2.11 Data collection procedure 
Training was given to the research personnel prior to the data collection. The training was 
focused on the demonstration to fill the questioner, collection of the data from the antenatal card. 
The way of communication with research participants and ethical issues were also discussed 
during the training period. The personals were also given information about the GDM in case the 
participant would like to know about GDM and its consequences. 
The main theme of the study was explained to the participants all the information given by the 
research participants was thoroughly reviewed to collect the required information.  For some the 
husband accompanied and asked the question on the behalf of their wives. The data was 
regularly cross check by the principal investigator. 
2.12 Diagnostic criteria used 
We depend on the method adopted by the KMC hospital for screening GDM. All pregnant 
women of gestation age between 24 and 28 weeks have to go for 50gm GCT. If the result of 
GCT ≥ 140mg% then had to undergo 75 gm OGTT. The GDM was diagnosed after performing 
OGTT based on WHO criteria. 
2.13 Variables 
The only dependent variable is GDM. All other variables used are independent variable. 
I. Socio demographic risk factor for mother-age, education qualification, occupation status 
of women, monthly income of women, physical activity 
II. Anthropometrical factor-  height ,prepregnancy weight, BMI(Body Mass Index) 
III. Obstetrical risk factor-  parity, , previous bad obstetrical history 
IV. Familial risk factor- previous history of GDM, previous positive history of diabetes and 
first degree relatives. 
V. Bio chemical variable – RBG, FBG, GCT OGTT, 
  Page 
26 
 
  
 2.14 Time of diagnosis of GDM 
Gestational week at which GDM was diagnosed 
2.15 Type of treatment in GDM 
For GDM patient if blood sugar detected high admitted and managed conservatively Firstly 
dietary control, if not by diet then insulin supplement is given. Then they were kept in regular 
follow ups. 
2.16 Pregnancy outcome variable  
2.16.1 primary outcome 
To know the prevalence of gestational diabetes mellitus. 
 2.16.2 Secondary outcome:  
To identify whether GDM is associated with maternal age, body mass index, occupation, physical 
activity, education, positive family history, diet. 
2.17 Operational definition of variables 
Maternal  age- age of the mother at the time of pregnancy 
Maternal height- height recorded in the antenatal card/ taken in the height machine 
Maternal weight(pre pregnancy)-weight of the mother prior to pregnancy 
BMI-  Body Mass Index  weight in kg 
2 
divided by height in m
2   
Physical activity- depends on the time spent on the physical activity or house hold activity or 
other activity such as walking, working in the office.
 
Education qualification-until what level he/she has studied in the studying institution. 
 Illiterate- those who have never gone to school and literate those who have gone to school.                     
Occupational status- women who do not earn anything are referred as house wife. Women who 
had their income are referred as employed. Women who are studying are referred to as student.  
Monthly expenditure- the monthly salary earned in Nepalese rupees. 
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Gravid – number of times she has become pregnant including abortion, still birth, intrauterine 
death. 
Parity – number of live child she has delivered. 
Bad obstetrical history- it relates to miscarriage,  obstructed labour or any serious complication 
during pregnancy, during delivery etc 
Abortion- death of the fetus before 24 weeks of gestation 
2.18 Anthropometrical measurements 
Anthropometric measurements of height and weight of pregnant women were taken wearing light 
clothes and without shoes. Height was taken while the woman stands in erect posture, touching 
the occiput, back, hip, and heels on a straight measuring wall, while she looks straight ahead. 
Then Weight was recorded to the nearest 0.1 kg weighing machines placed on a flat surface. Body 
mass index was calculated by the weight in (Kg) divided by height in (m
2
). 
2.19 Measurement of blood pressure 
For measuring the blood pressure (BP), special precaution was taken to reduce the variation of BP 
value with resting blood pressure. The women were asked to take rest for at least 5 minutes in 
sitting position before measuring the BP if they were exerted. Then the pressure was measured on 
the right arm using normal cuffs for adult fitted with a standard sphygmomanometer placing the 
stethoscope bell lightly over the brachial artery. Blood pressure was recorded to the nearest 2 
mmHg from the top of the mercury meniscus. Systolic pressure was recorded at the first 
appearance of sounds, and diastolic pressure was measured at phase V, which is the disappearance 
of sounds. 
2.20 BMI- Body Mass Index 
Around 6 kg is weight gain during pregnancy by the end of second trimester is normal (Dutta, 
2004). 
Pre-pregnancy BMI can be calculated as follows  
1. In the pregnant women with the known pre-pregnancy weight, BMI is calculated by weight- to 
height ratio of kg/m
2
. 
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2. In those with unknown pre-pregnancy weight, BMI can be calculated by subtracting the 
measured weight by expected weight gain in normal pregnancy (Institute of Medicine [IOM], 
2009). 
During pregnancy, the mother is encouraged to gain 3 kgs over the first 20 weeks and 0.5 kg 
every week until term. So, an average of 10-13 kgs of weight is gained during pregnancy. 
Generally, little weight is gained during the first trimester .The most weight is gained during 2
nd
 
trimester followed by the 3
rd
 trimester. 
For calculation of weight to be subtracted from current weight to calculate pre-pregnancy BMI if 
BMI was unknown prior to pregnancy. 
 Up to 20 weeks of gestation: Subtract 3 kgs from current weight  
 >20 weeks of gestation: Subtract 3.0 kgs plus 0.5 kg/week 
Categorization of BMI was accordance with recommendation for Asia-Pacific region by 
Western Pacific Regional Office of WHO (WPROWHO, 2000). The steering committee of the 
regional office for the western pacific region of WHO). . 
     Categories                                BMI (kg/m
2
) 
 Underweight                          <18.5 
 Normal weight                          18.5-22.9 
 Overweight at risk                         23-24.9 
 Obese I                                      25-29.9 
 Obese II                                      30 
In our study, we broadly divided into 2 categories, Underweight and normal weight in category I 
and overweight and obese in category II. The cut off points for BMI of underweight and Normal 
weight is <22.9 kg/m
2
, cut off points for overweight and obesity is >23kg/m
2
 is taken.  
2.21 Data handling   
In order to avoid mixing of data separate coding was done. The data was entered one by one by 
observing at the each questionnaire. The software package used was SPSS 20 (statistical package 
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for social science). The data was created on the answers to the questionnaire and also the 
antenatal card. Medical records were viewed thoroughly for the required information. 
2.22 Statistical  analysis 
SPSS version 20 is used to calculate frequency, distribution for maternal age, socio demographic 
factors, obstetrical history, familial histories and other variables as well. By using numbers and 
percentages data are summarized. Means, standard deviation are calculated for continuous 
variable (age, BMI). Univarate analysis was done to determine the crude odds ratio (ORs) and 
95% CI. Multivariate logistic regression is carried out for evaluation of effect modification. 
Correlation coefficient and logistic regression analysis will also be tested for observing 
association between GDM and BMI, GDM and diet. The analyses include descriptive and both 
univariate and multivariate binary logistic regression. Proportion and chi-square test are used to 
explore the relationship between maternal ages, parity, and positive family history for diabetes. 
Statistical inference is based on 95% confidence intervals (CIs) and the significance level is set at 
p value ≤ 0.05.    
2.23 Ethical issues 
Ethical review committee in Norway (REK) and Nepal Health Research Council (NHRC) gave 
the ethical approval to conduct a study The ethical approval was taken from the respective 
hospital to perform the  study. 
Informed written consent was taken from the participants. Appendix 1. The participants were 
told about the purpose and objective of the study. Participants were told that they could withdraw 
from the study any time, no reasons were asked about leaving the study. The given data were 
secured with confidentiality. That participant who could not write consent was taken from the 
witness.  
2.24 Data collection procedures and tools 
The principal investigator obtained the necessary information from the participants through the 
questionnaire. The research team were given training prior going to the field to get to know the 
research objectives and the matters concerning the ethical issues. Besides they should be well 
known about the disease to answer the participants‟ queries. A preliminary survey on data 
collection procedures and tools helped to get the necessary data required for the study. The 
reliability of the answers by the participants was counter check from the antenatal cards and the 
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medical records which participant bought to the hospital for their check – ups. 
2.25 Data Handling and record keeping 
 2.25.1 Confidentiality:  
The information from participants was kept confidential and managed according to the existing 
rules of institutional review committee is done. This was very important. 
 2.25.2 Records retention: 
Any tool regarding the study was destroyed at the completion of the study in accordance with the 
Health documentation destruction policy of institutional review committee.  
2.26 Potential risks    
As it is a cross sectional, there are no physical potential risks to research subjects. There may be 
risks associated with confidentiality.   
2.27 Potential benefits  
The findings will help to know the prevalence of gestational diabetes mellitus, associated risk 
indicator, monitor disease trends, and build an environment that will be helpful to encourage 
healthy lifestyles through various approaches, inter-disciplinary associations. 
 2.28 Conflict of interest:     
There is no potential conflict of interest in this study. 
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3 Result 
3.1 Descriptive analyses 
Table 1 Descriptive characteristics of the study participants 
 
Covariate 
GDM  
Total Yes No 
n (%)  22 (4.3) 488 (95.7) 510 
Age in years (Mean ± SD) 27.73 ± 4.18 25.55 ± 4.03 25.64 ± 4.06 
BMI (Mean ± SD) 27.21 ± 3.04 25.02 ± 3.36  25.12 ± 3.37 
 
Prevalence of GDM 
   
95% CI  with GDM 
Occupation:    
 Housewives 13 (2.5) 315 (61.8) (1.5- 4.3) 
 Employed 8 (1.6) 141 (27.6) (0.8- 3.1) 
 Student 1 (0.2) 32 (6.3) (0.03- 1.1) 
Economic:    
 ≤30000 15 (2.9) 407 (79.8) (1.8- 4.8) 
 >30000 7 (1.4) 81 (15.9) (0.7- 2.8) 
Education:    
 Illiterate 0 14 (2.7)  
 Literate 22 (4.3) 474 (92.9) (2.9- 6.4) 
Physical activity:    
 ≤5hours 4 (2.7) 374 (73.3) (1.6- 4.6) 
 6 hours 8 (1.6) 114 (22.4) (0.8- 3.1) 
*
Parity:    
 Primi 10 ( 2.2) 251 (54.9) (1.1- 3.6) 
 1 child 9 (2) 165 (36.1) (0.9- 3.3) 
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 2 or more 1 (0.2) 21 (4.6) (0.03- 1.1) 
Maternal age groups:    
 ≤20 years 1 (0.2) 51 (10) (0.03- 1.1) 
 21-30 years 15 (2.9) 384 (75.3) (1.8- 4.8) 
 31+ years 6 (1.2) 53 (10.4)           (0.5- 2.5) 
BMI:    
 18.5-22.9 2 (0.4) 153 (30)            (0.1- 1.4) 
 ≥23 20 (3.9) 335 (65.7)            (2.6- 6.0) 
*
2 GDM + cases had abortion 
 
Table 1 shows the descriptive characteristics of the study participants. A total of 510 women 
with an overall mean age of 25.64 years (± 4.06) and an average BMI of 25.12 (± 3.37) were 
enrolled during the study period. All women completed the study.  
The prevalence of GDM in urban antenatal clinic in Nepal is approximately 4.3%. As shown in 
Table 1, the prevalence is higher among housewives (2.5%) than among women who are 
employed (1.6%) and among female students (0.2%). Housewives with GDM 95%CI (1.5-4.3).   
The study also showed that women from households earning more than Rs. 30000 had a lower 
prevalence of 1.4% while the prevalence was estimated at 2.9% for women from households with 
earnings of less than Rs.30000 with 95%CI (0.7-2.8) and (1.8-4.8) respectively. For those who 
are literate, the prevalence of GDM is 4.3% and 95% CI (2.9-6.4). Pregnant women who do 5 
hours or less physical activity per day, have high prevalence of 2.7 % whereas women who work 
for at least 6 hours have a prevalence of 1.6%. The prevalence is high for women in the age 
group 21- 30 years (2.9%) and lowest in the age group ≤ 20 years (0.2%). Women in the age 
group 31 and above have a prevalence of 1.2%. Women who were pregnant for the first time 
have a GDM prevalence of 2.2 % [95% CI (1.1, 3.6)] whereas women with 1 or at least 2 
children have prevalence of 2% and 0.2% respectively. The estimated prevalence of GDM for 
women with a BMI < 22.9 kg/m
2
 is 0.4% and it is quite high in women with BMI >23 kg/m
2
 
(3.9%) with 95% CI (0.1-1.4) and (2.6-6.0) respectively. 
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3.2 Risk indicators of GDM 
Table 2 Odds ratios (OR) and their 95% CI showing the risk factors associated with GDM 
Covariate (risk factors) Univariate Multivariate 
 OR (95% CI) P-value OR (95% CI) P-value 
Ref age group: 21 – 30 years     
 ≤ 20 years 0.50 (0.06- 3.88) 0.5 0.93 (0.11- 8.31) 0.9 
 31+ 2.90 (1.08- 7.79)
 
0.03 3.32 (1.07- 10.26) 0.03 
     
Ref occupation: Housewives     
 Employed 1.38 (0.56- 3.39) 0.4 0.56 (0.14- 2.28) 0.4 
 Students 0.76 (0.10- 5.98) 0.7 1.05 (0.12- 9.29) 0.9 
     
**
Ref income: 10000-30000 Rs     
 >30000 2.35 (0.93- 5.93) 0.07 2.43 (0.89- 6.66) 0.08 
     
Time referent: <5 hours     
 ≥ 5 hours 1.88 ( 0.77- 4.58) 0.1 2.42 (0.61- 9.59) 0.2 
     
Ref parity: Primi     
 1 child 1.37 (0.55- 3.44) 0.5 1.04 (0.37- 2.91) 0.9 
 2
+
 children 1.20 (0.15- 9.79) 0.17 0.52 (0.05- 5.10) 0.5 
     
Ref BMI: 18.5-22.9 kg/m
2
     
 ≥ 23 kg/m2 4.57 (1.05- 19.79) 0.04 3.42 (0.76- 15.38) 0.1 
**
 Income in Nepali rupees. 
Table 2 shows results from binary logistic regression models; univariate (unadjusted) model and 
multivariate (adjusted) model. The risk of GDM among the 31+ age group is 2.90 times [95% CI 
(1.08, 7.79)] compared to women in the 21 – 30 age group. This risk increased to 3.32 [95% CI 
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(1.07, 10.26)] after controlling for income, occupation, physical activity, parity and BMI. 
Overweight and obese women whose BMI≥23Kg/m2 are at a higher risk of developing GDM with 
an odds ratio of 4.57[95% CI (1.05, 19.79)]. However this effect disappeared after adjusting for 
the other risk factors. The analysis did not reveal differences between women in occupations, 
economic status, physical activity and parity. 
 
 
3.3 Effect of diet on BMI 
Table 3 Prevalence of obesity between vegetarians and non-vegetarians 
 BMI GDM 
 18.5-22.9 ≥23 Yes No 
Vegetarian 15 (2.9) 21 (4.1) 4 (0.8) 32 (6.3) 
Non-vegetarian 140 (27.5) 334 (65.5) 18 (3.5) 456 (89.4) 
 
3.4 Effects of diet and age on both BMI and GDM 
Table 4 Binary logistic regression for the effects of diet and age on BMI and GDM 
 BMI GDM 
 OR (95% CI) P-value OR (95% CI) P-value 
Ref: Vegetarian     
 Non-vegetarian 1.70 (0.85- 3.40) 0.13 3.08 (1.00- 
9.79) 
0.05 
Ref: 21 – 30 years     
 ≤ 20 years 0.33 (0.19- 0.60) < 0.01 0.51 (0.07- 
3.97) 
0.52 
 31+ 2.68 (1.23- 5.82) 0.01 2.86 (1.06- 
7.76) 
0.04 
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Table 3 shows the prevalence of obesity and GDM among vegetarians and non-vegetarians. The 
prevalence is very low among vegetarians (4.1%) compared to non-vegetarians (65.5%). Non-
vegetarians have higher prevalence of GDM than vegetarians.  The effects of diet and age on both 
BMI and GDM are presented in Table 4. Here, the risk for being obese was 70% higher among 
non-vegetarians compared to vegetarians after adjusting for age. The study also showed that non-
vegetarians were 3-fold likely to develop GDM as compared to vegetarians. With age, the risk for 
developing GDM increased. The risk is 2.86 [95% CI (1.06, 7.76)] times among the 31+ age 
group compared to 21-30 age groups. However, the risk of developing obesity is lower by 67% 
among women in the age group ≤ 20 compared to women in the age group 31+ and it is 2.68 
times higher in the age group 31+. 
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  4 Discussion 
The purpose of the study was to determine the prevalence and associated risk indicators of GDM 
in Nepal. Knowledge about the prevalence and risk factors of GDM would help in giving early 
warnings to people and prevention measures established. 
4.1 Discussion on the findings of the study 
 Risk indicators for GDM 
 In our study we found increasing maternal age is risk for GDM. The mean age for GDM is 
27.73± 4.18 The age specific prevalence was higher in 21- 30 group was about 2.9%.  In the age 
group 31+ years the risk is nearly 2.9 folds higher compared to 21-30 age groups. After 
controlling for income, occupation, physical activity, parity and BMI the risk increased to 3.32 
fold with 95% CI [1.07-10.26]. With advancing age the risk of getting GDM also rises. The 
chance is 2.86 with 95 %( 1.06-7.76) times in 31 over age group as related to 21-30 years group. 
There were 86.7% of women age 25 years or more had GDM (Begum, Huda et al., 2002).  
Multiple studies showed that GDM had an association with increasing age, higher parity, higher 
pre-pregnancy weight and BMI, history of diabetes in first degree relatives, past history of 
gestational diabetes in various studies (Seshiah, Balaji, et.al, 2004; Zargar et al., 2004; Seshiah et 
al., 2008;  Metzger et al., 2007; Xiong, Saunders, & et al., 2001). A study in Hariyana showed 
prevalence of GDM increased significantly with increasing age (Rajput, Yadav & et al, 2013). In 
Pakistan also diagnosed by O‟Sullivan criteria half of the women with GDM were 25-30 years 
(Jawad & Irshaduddin, 1996).  Though in our study, no association was seen with other variables 
except for increasing age and in overweight and obese pregnant mothers. This is due to less 
number of positive cases of GDM. 
Pregnant women ≤20 years have least prevalence rate of 0.2%. There is less chance of developing 
GDM in younger age group than in advancing age. Mother‟s mean age at birth in Nepal is 20.1. 
The median age at first birth among women in Nepal is 25-29(WFB, 2014). Total 
fertility rate is 2.3 children born/woman.  
The prevalence of GDM for BMI i.e. ≥23 is 3.9% with 95% CI (2.6, 6.0) and <23 the estimated 
prevalence is 0.4% with 95% CI (0.1-1.4). The risk of having ≥23kg/m2 of BMI is 4.57 times 
higher than having low BMI of <23kg/m
2
, however disappeared after adjusting for other risk 
indicators. In our study GDM was found to be significantly higher in women with higher BMI and 
  Page 
39 
 
  
higher pre-pregnancy weight .Others‟ studies states that obesity is an important risk factor in the 
development of GDM
 
(Seshiah et al., 2008; Torloni, Betran, et.al, 2009). Higher prevalence of 
GDM in women with higher BMI has also been observed in earlier studies as well (Seshiah, et al., 
2008; Swami, Mehetre, et.al. 2008, Torloni, Betran, et.al. 2009). Saldana et al (Saldana, Siega-
Riz, Adair & Suchindran, 2006) observed that weight gain was significantly higher in women 
with gestational diabetes than in those with normal blood glucose. Bo et al
 
(Bo, Menato, 
Signorile, Bardelli, et al., 2003) had observed that hyperglycaemia in pregnancy was a risk factor 
for excess gestational weight gain. 
We found the prevalence of obesity in non-vegetarian is 65.5% and that of vegetarian is 4.1%. 
About 3.5% of non-vegetarian have GDM and those for vegetarian the prevalence is 0.8%. Our 
research showed there was 70% risk of being obese for non-vegetarian than vegetarian after 
adjusting for age. Non vegetarians are 3 times likely to develop GDM than vegetarians. Diet 
composition may be a modifiable predictor of risk for abnormal glucose tolerance during 
pregnancy. Previous studies suggest that diets high in total fat, saturated fat, red and processed 
meats, and with high glycogenic load increase the risk of developing GDM, while polyunsaturated 
fats, carbohydrates and fibers are protective (Jenny, Emilyo et al,2008). Jali (2011) al found that 
non-vegetarian pregnant women (61.5%) were more susceptible to develop abnormal glucose 
tolerance. It may be due to high fat, high calorie and low fiber diet. Recently, some of the studies 
have examined diet quality during pregnancy as a potentially modifiable contributor to GDM risk 
(Bo, Menato et al, 2001; Wang, Storlien et al., 2000; Saldana, Siega, 2004). In particular, Saldana 
et al (Salmeron, Manson et al., 1997) showed that higher intake of fat and lower intake of 
carbohydrates may be associated with increased risk of GDM and impaired glucose tolerance 
(IGT). High fiber intake, which has been consistently linked to decreased risk of type 2 diabetes 
mellitus among non-pregnant adults (Schulze, Liu et al., 2004; Meyer, Kushi et al., 
2000;Montonen , Knekt et al., 2003) was related to lower risk of GDM in two studies. Moses et al 
found that high intake of fatty diet lead to recurrent GDM in subsequent pregnancy compared to 
women in whom GDM did not recur (Moses, Shand et al., 1997; Zhang, Liu et al., 2006). 
The GDM prevalence was 4.3% for educated women in our study. Though education did not 
show any significance but a significantly higher prevalence of GDM was observed in other‟s 
studies with increasing educational level. This could be because of higher age of these women. 
Innes et al (Innes, Byers et al., 2002) had found an inverse association between the educational 
level of the pregnant woman and gestational diabetes mellitus. In another study carried out in Italy 
high levels of maternal education were found to be associated with reduced risks of GDM, 
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compared to less educated women (Bo, Marchisio, & et al., 2003).  Similar to our studies, study 
conducted byYang et al (Yang, et al, 2002) did not find an association between GDM and 
education in Chinese pregnant women.  
The prevalence was estimated 2.9 for those whose household earning was less than 30000. A 
significant association of gestational diabetes mellitus was seen with socio-economic status of the 
participants. This association could be related to multiple factors such as higher maternal age, 
higher pre-pregnancy weight and BMI, more sedentary lifestyle in women of higher socio-
economic status. In our study we did not find any association with socio economic status, 
similarly Yang et al (Yang et al, 2002)  did not find such an association in Chinese pregnant 
women while Keshavarz et al (Keshavarz , Cheung , et al., 2005) found an association between 
GDM with low socio-economic level in pregnant Iranian women (Bo et al., 2003).  
Family history of diabetes mellitus has been reported to be associated with higher chances of 
developing GDM(Seshiah , et al., 2008; Zargar , et al., 2004;  Swami , Mehetre , Shivane ,et.al., 
2008; Kim , Liu , Valdez  & Beckles, 2009). Seshiah (2008) observed a significant association 
between the family history of diabetes mellitus and the occurrence of GDM among pregnant 
women. A significant association between history of GDM in previous pregnancy and 
development of GDM in the index pregnancy was seen, though the number of women with past 
history of GDM was small (McGuire, Rauh, et al., 1996). The reason for not finding the 
significant association is due to low statistical power or the number of positive GDM cases is 
small in number. There was β error or type 2 error in our study. 
4.2 Methodological consideration 
4.2.1Study design 
A hospital based cross sectional study was conducted at Kathmandu medical college and 
teaching hospital.  Today people are health conscious so they go to hospital for regular check-
ups. On the other hand it also becomes easier for the researcher to conduct a hospital based study 
as it has become a convenient way to get the required data from the pregnant women. 
4.2.2 Selection of hospital  
Due to some internal problems at other hospitals, data was collected from Kathmandu medical 
college and teaching hospital only. 
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4.2.3 Diagnostic criteria of GDM  
We could not take the fasting blood sample as per protocol because the women were not willing 
to do so after being invited. Thus we relied on data that was collected by the hospitals. All 
pregnant women undergo 50gm GCT at 24 to 28 weeks of gestation. If GCT ≥140mg% then 
OGTT was performed to confirm GDM. 
4.2.4 Sampling technique and sampling size 
All eligible pregnant women coming to the hospital between 24 and 28 weeks of gestation were 
recruited for study  
4.2.5 Response of the participants and data collection 
The interview depended mainly on the participants‟ information. There was no system to check 
participants‟ personal details such as birth registration, medical records. Sometimes the reports 
could have been misleading because of recall bias. We had to rely on the antenatal cards and the 
story of the participants. 
4.3 Methodical discussion 
4.3.1 Strength of the study 
The principal investigator obtained the data from the participants. Adequately trained assistants 
helped to collect data and respond the queries of participants. A study measures the exposure and 
disease occurrence at the same point in time. The analysis was done individually. Multiple effects 
of the risk indicators can be tested at the same time. Multiple exposure and determinants can be 
studied nicely. Cross checking and validating forms and data entry was done finely otherwise 
reliability of the results would be influenced. This study can be taken as reference since very few 
studies has been conducted in Nepal. As I am a medical person it has been easy to win their 
confidence to take part in the research. A cross sectional study is particularly suitable for 
estimating the prevalence of a behavior or disease in a population and my main objective is to 
estimate the prevalence. 
4.3.2 Limitation of the study 
The cross section study limits the underlying interference between exposure and disease 
outcome.  
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4.3.2.1 Confounding factor 
The positive sample for GDM was small enough to see the association, so for most of the variable 
the result showed insignificant. It was difficult to measure the time relationship in our study.  
4.3.2.2 Biases 
Selection bias 
The sample collected was from only one hospital and non-random sampling technique caused 
potential limitation on the selected samples only. The patient coming to the hospital represented 
a part of the general population for antenatal check-ups. 
 Recall and reporting bias 
There was a greater chance of recall bias as participants forget to recall their past. To some 
questions participants feel embarrassed for which they hide the truth for instance abortion cases, 
age etc., this leads to reporting bias. 
Interview bias  
Questionnaire is stereotype so participant may feel uncomfortable to answer. Inconsistency in 
questioning may occur.   First impression error so participants have feared to answer the question 
though everything has been told. 
4.4 Internal validity of the findings 
The research is based on the hospital record that has been collected from the client‟s antenatal 
card. The questionnaire is prepared by the researcher herself. 
4.5 External validity for generalization 
The findings of the study are based on pregnant women between 24 and 28 weeks of pregnancy 
coming from village and municipality area to the respective hospital for the check-up. 
4.6  Reliability 
The question is asked directly to the client. This allows the information lacking in the 
questionnaire can be corrected. Collecting data in a prospective way is helpful doubt can be 
clarified. 
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5.1 Implication of our study 
Our study can be used for further studies on diabetes and GDM. The antenatal clinics can have the 
zest on GDM so pregnant women are aware of the disease. This study can also be used as 
campaign for preventing obesity for GDM and DM. 
5.2 Conclusion  
The prevalence of GDM was found to be 4.3% in KMCTH, Kathmandu. There need to be 
appropriate intervention to control GDM and also risk indicator modification s in order to avoid 
complication regarding to mother and child. Every clinician must do through check-ups or follow 
ups GDM cases after delivery to avoid from developing type 2 diabetes. GDM is a major health 
challenge for both mother and the child. So it is a duty of a doctor to treat it in the best possible 
way to lower maternal and fetal complications. 
In summary, our study showed that advancing maternal age, overweight and obesity  were a risk 
indicator for GDM. However, other risk indicators should not be neglected because multiple 
studies showed that they were also equally important risk factors for GDM. We could not find an 
association with important risk indicators possibly because of low statistical power. Timely 
check-ups and screening is recommended. 
5.3 Recommendation 
1) All pregnant women should visit the hospital/clinic/ health post for antenatal check-ups. 
2) Screening for GDM must be performed compulsory to all pregnant mothers. 
3) A proper guideline for GDM must be formulated so no pregnant women should be devoid 
from screening. 
4) If GDM diagnosed, proper management should be performed to avoid complication. 
5) Proper monitoring of the GDM patient who are taking insulin therapy. 
6) GDM patient should be followed up post-partum for blood glucose status and required 
advised should be given to them.  
7) GDM patient should not avoid health status of self and it is the right of her to get to know 
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the disease well so to get to aware of the consequences. 
6. Further research obligatory 
1)  Our study found the increasing age is risk factor for GDM, so better to see the cut off age 
of the mother acquiring GDM. 
2) A study on GDM with grades of hypertension among pregnant women in Nepal  
3) GDM with modes of delivery and assessment of maternal and fetal outcome. 
4) Chance of having type 2 diabetes to GDM mothers in subsequent pregnancies. 
5) Promotion of health lessening the burden of disease by controlling GDM 
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Appendix 1 
Informed consent form for pregnant woman 
You are being invited to participate in a Gestational Diabetes Mellitus Research study. This 
form is designed to provide you with information about the study. The investigators or 
representative describes this study to you and answer any of your questions. .I am going to 
give you information and invite you to be part of this research. You do not have to decide 
today whether or not you will participate in the research. Before you decide, you can talk to 
anyone you feel comfortable with about the research. There may be some words that you do 
not understand. Please ask me to stop as we go through the information and I will take time to 
explain.  If you have questions later, you can ask them of me, the study doctor or the staff. 
Title of project: “Prevalence of Gestational Diabetes Mellitus and associated risk 
indicator in urban antenatal clinic in Nepal”  
Gestational diabetes mellitus is increasingly dramatically worldwide in the recent decades. It 
is one of the causes of maternal and fetal mortality and morbidity. Nearly half of women with 
a history of GDM go on to develop type 2 diabetes within five to ten years after delivery. It 
develops in 1 in 25 pregnancies worldwide and is associated with complications in the period 
immediately before and after birth. . 
Potential risks     
As it is a cross sectional, there are no physical potential risks to research subjects. There may 
be risks associated with confidentiality.     
Potential benefits  
The findings will help to know the prevalence of gestational diabetes mellitus, associated risk 
indicator monitor disease trends, and build an environment that will be helpful to encourage 
healthy lifestyles through various approaches, inter-disciplinary associations. 
This is to certify that I………………………… hereby agree to participate as a volunteer in 
an authorized research project. 
I understand the purpose of this research as mentioned above. The procedure involves 
determining the prevalence of gestational diabetes mellitus and associated risk indicator 
among pregnant women between 24-28 weeks of pregnancy. I also know that beside routine 
health check-ups for blood tests and ultrasonography. I also will have to perform Oral 
glucose tolerance test. 
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I understand that all the information which is obtained from me will be confidential in an 
appropriate manner.  
Participation is voluntary and I understand that I am free to refuse to participate in a 
procedure or to refuse to answer any question at any time without prejudice to me. I 
understand that I am free to withdraw my consent and to withdraw from the study any time 
without prejudice to me.  
I understand that the research investigators named above will answer any of my questions 
about the research procedures, my rights as a subjects and research-related injuries time. 
I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions that I have asked have been 
answered to my satisfaction.  I consent voluntarily to participate as a participant in this 
research. 
 
Print Name of Participant__________________      
Signature of Participant ___________________ 
Date ___________________________ 
 Day/month/year    
     
If illiterate 
A literate witness must sign (if possible, this person should be selected by the participant and 
should have no connection to the research team). Participants who are illiterate should 
include their thumb-print as well.   
I have witnessed the accurate reading of the consent form to the potential participant, 
and the individual has had the opportunity to ask questions. I confirm that the 
individual has given consent freely.  
 
 Name of witness_____________________             AND         Thumb print of participant 
Signature of witness ______________________ 
Date ________________________ 
                Day/month/year 
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Statement by the researcher/person taking consent 
I  have accurately read out the information sheet to the potential participant, and to 
the best of my ability made sure that the participant understands that the following will 
be done: 
1. 
2. 
I confirm that the participant was given an opportunity to ask questions about the 
study, and all the questions asked by the participant have been answered correctly and 
to the best of my ability. I confirm that the individual has not been coerced into giving 
consent, and the consent has been given freely and voluntarily.  
   
 A copy of this ICF has been provided to the participant. 
Print Name of Researcher/person taking the consent________________________ 
    
Signature of Researcher /person taking the consent__________________________ 
Date ___________________________    
                 Day/month/year 
 
Note: If you have any questions or complaints about the informed consent process or policy, 
please contact investigators (s). Thank you! 
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Appendix 2 
Questionnaire 
1. Date -----------------------------------                                                   Code No. ------------- 
2. Personal History  
2.1. Name of the Patient ---------------------------------------------------- 
2.2. Wife of, Daughter of    ---------------------------------------------- 
2.3. Age -------------------Years 
2.4. Marital status   -   (Married / Single / Widow) 
2.5. Occupation   --------------------------------------- 
3. Address  
3.1 Permanent Address 
House No. ------------------- Street --------------------------------------- Ward No. ------- 
Village/Municipality ----------------------------------- District----------------------- 
3.2 Temporary Address 
House No. ------------------- Street --------------------------------------- Ward No. ------- 
Village/Municipality ----------------------------------- District----------------------- 
3.3 Contact no.  Office -------------------------- Residence ---------------------------- 
2.8. Education    ---------------------------------- 
2.9 Education of Husband ------------------------------------- 
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3. Personal History  
3.1. Family History (Yes =1, No =2, Unknown=3) 
 1. DM 2. HTN 3. IHD 
 1 2 3 1 2 3 1 2 3 
Grand parents          
Father          
Mother          
Brother/sister          
Sons/daughters          
 
3.2. Physical activity (hours/day) ---------------------------------- 
 
4. History of Past illness 
4.1.  
SL Name of Diseases (Yes =1, No =2, 
Unknown=3)& 
date of diagnosis 
Are you currently 
taking any medication 
(1. Yes 2. No) 
Medicine 
Name 
1 Diabetes    
2 High blood pressure    
3 Stroke    
4 Heart Attack    
5 Foot ulceration    
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5. Obstetric History  
5..1 Total number of children --------------- 
5.2. Number of Miscarriages/ Abortions ---------------- 
5.3. Number of Still Births ------------------------- 
5.4. Modes of Delivery – Normal/ caesarian / Vaccum / others 
5.5. Cause of  cesarian /vaccum  in past delivery ----------------------------- 
5.6. Weight of baby in previous delivery -------------------------------- 
5.7. Any congenital abnormality--------------------------- 
5.8. Any type of sickness during pregnancy----------------------------------- 
5.9.  Age of last child--------------------- 
6. Menstrual History 
6.1. Menstrual cycle ------------------- 
6.2. Duration of flow ------------------ 
7. Physical examination 
7.1. Blood Pressure      --------------    mmHg 
7.2. Height                 --------------    cm 
7.3. Weight                 -------------     Kg 
 
8. Blood test result 
                                                                       
Name of the test 
Result 
FPG (mg/dl)  
Oral glucose tolerance test (mg/dl)  
Total Cholesterol  
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TG  
HDL  
LDL  
Hemoglobin  
9. Food habit  
9.1. Total number of meal ----------------------------- 
9.2. Most of the time type of meal taken -------------------------------------------------- 
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Appendix 3 questionnaire in Nepali 
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Appendix 4 
Consent form in Nepali language 
 
